AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2024
Jan 23, 2024
35475_dirs_2024-01-23_631290a1-624e-4fa1-9f20-995d7c8c60b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2024-01-22
Reporting Person: Meckler Jeffrey A (Director, CEO and Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-22 | Stock Option (Right to Buy) | $1.74 | A | 100000 | Acquired | 2034-01-22 | Common Stock (100000) | Direct |
Footnotes
F1: The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027.
More from Indaptus Therapeutics, Inc.
Board/Management Information
2026
Jun 5
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12